Big Pharma Dominates Ranking Of Stocks With Best Five-Year Returns
Breakthrough: University of Cambridge Scientists Grow Two-Week-Old Human Embryos in the Lab For the First Time
The Science Of How Alcohol Won't Bring You Long-Term Happiness, University of Kent Study
Yeast Infection Linked To Mental Illness, Johns Hopkins University School of Medicine Study
Medical Errors Now Third Leading Cause Of Death In The U.S., Johns Hopkins University School of Medicine Study
Human Extinction Isn't That Unlikely
Expert Explains Why Autism More Common In Boys, Cold Spring Harbor Laboratory Study
How Your Brain Uses Statistics to Boost Your Confidence, Cold Spring Harbor Laboratory Study
Bipolar Disorder Has Genetic Links To Autism, University of Iowa Study Suggests
Concerns Grow Over Getting High On Anti-Diarrheal Drug, Published In Annals Of Emergency Medicine
The Fatal Flaw In Medical Device Design
3 Medical Devices Stocks Set To Beat This Earnings Season
Virtual Reality Can Help Treat Severe Paranoia, Oxford University Study Finds
"Kidney On A Chip" Could Lead To Safer Drug Dosing, University of Michigan Study
From Autism To Chinese, A Headset To Help You With Your Language, University of California, Irvine Study
Equilibrium Modeling Increases Contact Lens Comfort, Rochester Institute Of Technology Study
The Importance Of Implementing CF Newborn Screening Reinforced, McGill University Study
New Research Tests Whether Early Depression Relapse Detection Can Achieve 30% Fewer Full Episodes, Oxford University Study
See All News >
Theranos Allegedly Sent Team of Five Lawyers to Wall Street Journal to Squash Story
Biogen (BIIB) Spinning Off Hemophilia Business to Focus On Neurological Disorders
3 Stocks with Moonshot Potential that are Safer Buys than bluebird bio (BLUE)
Amid Hemophilia Spinoff, Biogen (BIIB)’s Head of Strategy Returns to Bain Capital
IMS Health, Quintiles (Q) to Merge to Form $23 Billion Power House
Why a Medivation (MDVN) Takeover Just Got a Little Tougher for Potential Suitors Like AstraZeneca PLC (AZN), Pfizer (PFE) and Sanofi (SNY)
Delaware Employees Nervous Over AstraZeneca PLC (AZN)'s $1 Billion Cost-Cutting Plans
Federal Judge Reopens Gilead (GILD) Case Amid Allegations Former Merck & Co. (MRK) Scientist Lied
Backed by Celgene (CELG) and Novartis AG (NVS), IDEAYA Biosciences Raises $46 Million and Recruits an Arsenal Full of Industry Vets
Pfizer (PFE) Rumored to be Selling Its Hospira Pumps Division, With Smiths Group, Fresenius SE and Pamplona Capital Bidding
Ionis Pharma (IONS), Kastle Forge $95 Million KYNAMRO Deal
Dynavax (DVAX)'s Possible Hep B Win Could Prove a Threat to GlaxoSmithKline (GSK)
Why Sarepta (SRPT) Didn't Start a Big DMD Trial Quicker
Cambridge's BIND Therapeutics (BIND) Files for Chapter 11 and Reviews Strategic Alternatives
MVM Life Science Partners Closes $233 Million Healthcare Fund
Novartis AG (NVS)'s Chief Ethics and Compliance Officer Retires
The Blues Singer Who Created America's Hated Drug-Pricing Model
Eli Lilly (LLY) Warns of Job Cuts at Irish Plant
See All News >